5:26 PM
Nov 27, 2017
 |  BC Innovations  |  Distillery Therapeutics

Infectious disease


Cell culture and human sample studies identified combinations of Plasmodium falciparum antigens that could be used to develop a malaria vaccine. In a human erythrocyte-based assay of P. falciparum growth, polyclonal rabbit IgGs against five parasitic antigens -- P. falciparum SERA9, MSP5, eba-181, CyRPA and RAMA -- inhibited growth of two parasitic strains with...

Read the full 254 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >